Anthera Pharma (ANTH) Misses Q2 EPS by 4c
Anthera Pharma (NASDAQ: ANTH) reported Q2 EPS of ($0.35), $0.04 worse than the analyst estimate of ($0.31).
For earnings history and earnings-related data on Anthera Pharma (ANTH) click here.
Anthera Pharma (NASDAQ: ANTH) reported Q2 EPS of ($0.35), $0.04 worse than the analyst estimate of ($0.31).
For earnings history and earnings-related data on Anthera Pharma (ANTH) click here.